Taiwan FDA Releases Latest Findings on Carcinogen-Tainted Oil Case
Taiwan’s Food and Drug Administration has published the independent third-party investigation into Central Union Oil’s recent product contamination case. The report revealed that while production machinery did not directly generate the Group 1 carcinogen Benzopyrene (BaP), structural failures allowed it to pass through. Investigators flagged significant gaps in risk control.
